FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Boehringer Ingelheim

BioTrove Installs First European RapidFire System at Boehringer Ingelheim and Obtains CE Mark for the Instrument

24-Jul-2009 - BioTrove, Inc. announced its RapidFire® High-Throughput Mass Spectrometry (RF-MS) screening platform was installed in its first European customer site at Boehringer Ingelheim in Biberach, Germany. The RapidFire system, which is being used for expanded in vitro ADME applications at Boehringer ...

Boehringer Ingelheim Germany mass spectrometry

Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery

04-Feb-2009 - Cenix BioScience GmbH announced that it has signed a research agreement to support Boehringer Ingelheim in its ongoing efforts to discover novel therapeutic drug targets. Cenix will apply its expertise in combining high throughput (HT) applications of RNAi-based gene silencing with high content ...

Boehringer Ingelheim Cenix BioScience drug development +5

Kinaxo Enters into an Agreement with Boehringer Ingelheim

15-Oct-2008 - Kinaxo Biotechnologies GmbH announced that it has entered into a two-year collaboration with Boehringer Ingelheim. Under the agreement Kinaxo will apply its new platform technologies to studies on drug mode of action and target identification. Financial details of the agreement were not ...

Acetylation biomarkers Boehringer Ingelheim +5

Boehringer Ingelheim to acquire STEAG microParts GmbH

16-Sep-2004 - Boehringer Ingelheim is to acquire the microtechnology specialist STEAG microParts GmbH from STEAG AG, Essen, Germany. STEAG microParts, established in 1990, is a worldwide leader in microsystem technology with headquarters at the hub of technology in Dortmund, Germany. STEAG microParts' core ...

Boehringer Ingelheim clinical trials Germany